State Board of Administration of Florida Retirement System Trims Stake in Agilent Technologies Inc (A)

State Board of Administration of Florida Retirement System cut its holdings in Agilent Technologies Inc (NYSE:A) by 0.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 474,407 shares of the medical research company’s stock after selling 850 shares during the period. State Board of Administration of Florida Retirement System owned about 0.15% of Agilent Technologies worth $33,465,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of A. SRS Capital Advisors Inc. grew its holdings in Agilent Technologies by 75.9% during the 2nd quarter. SRS Capital Advisors Inc. now owns 1,791 shares of the medical research company’s stock valued at $110,000 after purchasing an additional 773 shares during the last quarter. Moneta Group Investment Advisors LLC grew its holdings in Agilent Technologies by 391.7% during the 2nd quarter. Moneta Group Investment Advisors LLC now owns 6,023 shares of the medical research company’s stock valued at $158,000 after purchasing an additional 4,798 shares during the last quarter. TRUE Private Wealth Advisors bought a new position in Agilent Technologies during the 3rd quarter valued at about $181,000. Bray Capital Advisors grew its holdings in Agilent Technologies by 12,000.0% during the 2nd quarter. Bray Capital Advisors now owns 3,025 shares of the medical research company’s stock valued at $187,000 after purchasing an additional 3,000 shares during the last quarter. Finally, AMG National Trust Bank bought a new position in Agilent Technologies during the 3rd quarter valued at about $212,000.

In other news, Director Paul N. Clark sold 2,876 shares of the company’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $68.60, for a total value of $197,293.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Heidi Fields sold 5,482 shares of the company’s stock in a transaction that occurred on Tuesday, September 11th. The stock was sold at an average price of $67.73, for a total transaction of $371,295.86. The disclosure for this sale can be found here.

Several equities analysts recently commented on A shares. Morgan Stanley upped their price target on shares of Agilent Technologies from $84.00 to $86.00 and gave the company an “overweight” rating in a report on Wednesday, October 10th. Goldman Sachs Group reiterated a “buy” rating and set a $82.00 price target (up from $77.00) on shares of Agilent Technologies in a report on Tuesday, September 18th. ValuEngine upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday. Zacks Investment Research downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, October 16th. Finally, Deutsche Bank upped their price target on shares of Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, August 15th. One investment analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $77.44.

Shares of A stock opened at $65.91 on Tuesday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 3.00 and a current ratio of 3.62. The stock has a market capitalization of $21.02 billion, a price-to-earnings ratio of 24.88, a P/E/G ratio of 2.06 and a beta of 1.35. Agilent Technologies Inc has a one year low of $60.42 and a one year high of $75.00.

Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, August 14th. The medical research company reported $0.67 EPS for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.04. The business had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.20 billion. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.59 EPS. On average, equities analysts forecast that Agilent Technologies Inc will post 2.71 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 24th. Shareholders of record on Tuesday, October 2nd were paid a $0.149 dividend. The ex-dividend date was Monday, October 1st. This represents a $0.60 dividend on an annualized basis and a yield of 0.90%. Agilent Technologies’s dividend payout ratio is currently 25.42%.

WARNING: This article was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/11/06/state-board-of-administration-of-florida-retirement-system-trims-stake-in-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: Return on Investment (ROI) Defined, Explained

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply